HIL workers at Kerala Endosulfan plant seek probe into NIOH study

Image
Announcement Corporate
Last Updated : Jan 21 2013 | 6:57 AM IST

Over 300 workers from the Hindustan Insecticides Limited plant manufacturing Endosulfan near Kochi at Kerala organised a rally today to oppose the unscientific approach adopted by environmental NGOs to seek ban on Endosulfan.

The workers demanded that their own experience and the farmers’ experience be taken into consideration as they work with the pesticide Endosulfan. Endosulfan was manufactured and used for more than 50 years across the world and continues to be in use in many countries without any ill effects to humans or environment. Endosulfan has proved to be harmless to beneficial insects and pollinating agents such as honey bees etc. It is among the top five insecticides in the world. In relation to Endosulfan’s use inside India the workers argued that Endosulfan would have shown its harmful effects elsewhere in India as it is extensively used across the country on crops such as cotton, sugarcane, spices, vegetables, fruits, etc. Millions of Indian farmers have been using Endosulfan for over 35 years and continue to use it as it has been cost effective and safe.

Speaking during the dharna, one of the workers’ representatives pointed out that Kerala had stopped use of Endosulfan in 2002 and it is strange that the harmful effects were brought to light only recently. Endosulfan was sprayed across 10000 acres of Cashew crops throughout Kerala, prior to the ban - had Endosulfan been the cause of physical problems inside Kasargod, the Kerala state should have witnessed similar cases elsewhere as well.

The workers’ representatives added that studies conducted by Kerala Sasthra Sahitya Parishad, Achuthan Commission, Kerala Agriculture University, IMA, Dubey Committee have concluded of no linkage between use of Endosulfan and the reports of health problems to the use of Endosulfan on the health problems reported at the Kasargod district of Kerala. All these studies have been conducted as recently as in the last eight years. It is their demand that, rather than ensuing a new study on the pesticide Endosulfan, it will be relevant to seek an independent investigation into the flaws observed in the study which was released by the National Institute of Occupational Health (NIOH).

The NIOH study was adopted by NGOs for propaganda against the generic pesticide Endosulfan since year 2002. To prove this point, the workers demanded that their blood samples be tested to validate against the published findings in NIOH report. The workers also made observations that the campaign against Endosulfan led by environmental NGOs like Thanal is suspect on their motives in the backdrop of studies conducted by other bodies. Based on unscientific approach, the demands made by local NGOs should not be taken into account for considering such a serious decision affecting our country’s agriculture and food security.

There are over 6000 workers employed in the manufacturing of Endosulfan in various plants of India and 400 of these workers are employed in the HIL plant.

 

 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 18 2010 | 2:31 PM IST

Next Story